IDH2 and breast carcinoma: Also, estrogen receptor-negative (ER−) breast carcinoma HTB-126/Hs 578T cells, and epithelial adenocarcinoma MDA-MB-231 cells, contain 2HG in the absence of IDH2 mutations and its formation substantially dropped upon IDH2 silencing (155).